6533b7defe1ef96bd1275b86
RESEARCH PRODUCT
Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome
B. HenningS. BittnerF. ZippCarmen LoquaiF. LuessiS. Engelsubject
OncologyCobimetinibmedicine.medical_specialtyCombination therapybusiness.industryMelanomaPosterior reversible encephalopathy syndromeHematologymedicine.diseasechemistry.chemical_compoundText miningOncologychemistryInternal medicinemedicineVemurafenibbusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2019-06-01 | Annals of Oncology |